5 Results for "

Interstitial cystitis

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Interstitial cystitis" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-A0203A
CAS No.: 140207-93-8
Target:  

HIV

Pentosan Polysulfate Sodium is an orally bioavailable, semi-synthetic medication with anti-inflammatory and pro-chondrogenic properties. Pentosan Polysulfate Sodium also is a potent and selective anti-HIV agent. Pentosan Polysulfate Sodium is used for the treatment of interstitial cystitis .
loading...
    loading...
Cat. No.: HY-A0203
CAS No.: 37300-21-3
Target:  

HIV

Research Areas:  

Infection Inflammation/Immunology

Pentosan Polysulfate is an orally bioavailable medication with anti-inflammatory and pro-chondrogenic properties. Pentosan Polysulfate also displays a potent and selective anti-HIV activity. Pentosan Polysulfatecan be used for the research of interstitial cystitis .
loading...
    loading...
Cat. No.: HY-110198
CAS No.: 459841-96-4
Research Areas:  

Inflammation/Immunology

ONO-8130 is an orally active and selective prostanoid EP1 receptor antagonist. ONO-8130 blocks phosphorylation of ERK in the L6 spinal cord. ONO-8130 relieves bladder pain in mice with cyclophosphamide-induced cystitis. ONO-8130 can be used for interstitial cystitis research .
loading...
    loading...
Cat. No.: HY-169115
CAS No.: 313651-33-1
Target:  

Calcium Channel

Research Areas:  

Inflammation/Immunology

PD-0299685 is a potent Ca 2+ channel α2δ ligand. PD-0299685 is promising for research of refractory genito-urinary pain and interstitial cystitis/bladder pain syndrome .
loading...
    loading...
Cat. No.: HY-169115A
CAS No.: 313651-02-4
Target:  

Calcium Channel

Research Areas:  

Inflammation/Immunology

(Rac)-PD0299685 is a Ca(2+) channel α2δ ligand that was investigated for relieving interstitial cystitis pain in a randomized, double-blind, placebo-controlled phase IIa study. (Rac)-PD0299685 demonstrated a clinically significant reduction in daily worst pain severity scores at the 60 mg dose compared to placebo. (Rac)-PD0299685 is also a potent voltage-dependent calcium channel inhibitor for the study of retina-related diseases.
loading...
    loading...